Emerging Supplements in 2025: What the Research Sh…

Supplement science moves faster than most people realize. Each year, compounds that spent decades in obscurity emerge from animal research and early clinical trials with enough evidence to warrant serious attention. 2025 has been a particularly rich year, with multiple compounds advancing through human research with compelling results. Here is a research-grounded overview of the most significant emerging supplements.

Urolithin A: Mitophagy Activation for Muscle and Longevity

Urolithin A is a postbiotic compound produced when gut bacteria metabolize ellagitannins—polyphenols found in pomegranates, walnuts, and berries. Its primary mechanism is activation of mitophagy: the cellular process of clearing damaged mitochondria and replacing them with healthy ones. Impaired mitophagy is a central feature of aging muscle and a contributor to sarcopenia.

In a landmark 2022 clinical trial published in Nature Aging, Urolithin A supplementation in older adults improved muscle function and mitochondrial markers significantly compared to placebo. A 2023 follow-up confirmed improvements in exercise capacity and muscle endurance. Mitopure, a clinically validated form of Urolithin A, has become one of the most rapidly adopted longevity supplements among health-conscious consumers and practitioners.

Taurine: Longevity Factor Revealed in 2023

A landmark 2023 study in Science demonstrated that taurine—an amino acid found in meat and seafood—declines significantly with age and that supplementing it extends healthy lifespan in mice and worms by 10–12% while improving multiple aging biomarkers. Taurine levels in 60-year-old humans are approximately 80% lower than in 5-year-olds.

The study identified taurine as a potential "longevity factor" and prompted enormous interest given taurine's established safety record, low cost, and wide availability. Human supplementation studies at doses of 3–6 g/day are now underway to characterize its effects on human aging biomarkers.

Alpha-Ketoglutarate (AKG): Epigenetic Rejuvenation

Alpha-ketoglutarate (AKG) is a central metabolite in the Krebs cycle that also serves as a cofactor for ten-eleven translocation (TET) enzymes involved in DNA methylation—a key epigenetic mechanism tied to biological age. AKG levels decline significantly with age.

A 2020 human trial of calcium AKG (CaAKG) in adults aged 45–65 found a reduction in biological age by approximately 8 years as measured by DNA methylation clocks. Participants also showed improvements in physical function and inflammatory markers. This represents one of the few human studies demonstrating epigenetic age reversal with a supplement intervention.

Spermidine: Autophagy and Epigenetic Reset

Spermidine is a naturally occurring polyamine found in high concentrations in wheat germ, aged cheese, and fermented foods. It induces autophagy—the cellular recycling process that removes damaged proteins and organelles—and has been shown in multiple studies to extend lifespan in yeast, flies, worms, and mice.

In humans, higher dietary spermidine intake is associated with reduced cardiovascular and cancer mortality. A randomized controlled trial found spermidine supplementation improved memory in older adults at risk for dementia. It also appears to modulate the epigenome in ways that slow biological aging markers.

5-Amino-1MQ: The Fat Cell Reprogramming Compound

5-Amino-1MQ is an NNMT (nicotinamide N-methyltransferase) inhibitor that reprograms fat cells from energy-storing to energy-burning states by elevating NAD+ levels and activating SIRT1. Animal research shows significant fat mass reduction and metabolic improvements without caloric restriction.

While still in early human research stages, 5-Amino-1MQ has attracted attention as a mechanistically distinct approach to obesity that operates on fat cell metabolism itself rather than appetite or thermogenesis.

Lithium Orotate: Neuroprotection at Microdoses

Low-dose lithium has emerged as one of the most intriguing neuroprotective supplements in epidemiological and early clinical research. Population studies consistently find lower dementia rates in regions with higher natural lithium levels in drinking water. Lithium orotate provides low doses (1–5 mg) versus the pharmacological doses (300–1800 mg) used in psychiatry, with a favorable safety profile.

Proposed mechanisms include BDNF upregulation, neuroprotective gene expression, GSK-3beta inhibition, and mitochondrial support—making it one of the more mechanistically rich micronutrient candidates in longevity research.

FAQ

Q: Which 2025 supplement has the strongest human evidence? A: Urolithin A (Mitopure) has the most robust human clinical trial data, including randomized controlled trials showing improvements in muscle function and mitochondrial health.

Q: Is taurine supplementation safe at the doses studied for longevity? A: Taurine has an excellent safety profile at 3–6 g/day, with decades of use in energy drinks and clinical settings at these doses.

Q: How long does it take alpha-ketoglutarate to show epigenetic effects? A: The landmark human study observed biological age changes over a 7-month period; shorter-term effects on energy and inflammation may appear sooner.

Q: Can multiple emerging supplements be safely combined? A: Many of these compounds (Urolithin A, taurine, AKG, spermidine) have complementary mechanisms and are commonly combined in longevity protocols without known interactions.

Track your supplements in Optimize.

Emerging Supplements in 2025: What the Research Shows